Chi sono

Ho svolto attività clinico-sperimentale per la durata del corso di specializzazione presso la U.O. di Urologia e Trapianto di Rene, diretta dal prof. Francesco P. Selvaggi.

Dal dicembre 2004 a luglio 2007 ho svolto servizio con la qualifica di Dirigente Medico di I livello presso la U.O. di Urologia dell’Ospedale “Madonna delle Grazie” di Matera.

Da agosto 2007 sono in servizio presso l’U.O. di Urologia Universitaria e Centro Trapianti di Rene dell’Università di Foggia, diretta dal prof. Giuseppe Carrieri.

Attualmente sono responsabile del servizio di Uro-oncologia.

Multicentre experience with ZSI 375 artificial urinary sphincter for the treatment of stress urinary incontinence in men
Ostrowski I, Blewniewski M, Neugart F, von Heyden B, Selvaggio O, Iori F, Foley S, Fernández Arjona M, Carvajal Obando A, Pottek T.
Urologia. 2017 Aug 1;84(3):148-152. doi: 10.5301/uj.5000246
Epub 2017 May 29. PubMed PMID: 28574143

Abiraterone Acetate for Treatment of Metastatic Castration-resistant Prostate Cancer in Chemotherapy-naive Patients: An Italian Analysis of Patients’ Satisfaction
Cindolo L, Natoli C, De Nunzio C, De Tursi M, Valeriani M, Giacinti S, Micali S, Rizzo M, Bianchi G, Martorana E, Scarcia M, Ludovico GM, Bove P, Laudisi A, Selvaggio O, Carrieri G, Bada M, Castellan P, Topazio L, Boccasile S, Ditonno P, Chiodini P, Schips L.
Clin Genitourin Cancer. 2017 Oct;15(5):520-525. doi: 10.1016/j.clgc.2017.04.003
Epub 2017 Apr 11. PubMed PMID: 28478884

Prognostic Factors for Anastomotic Urinary Leakage Following Retropubic Radical Prostatectomy and Correlation With Voiding Outcomes
Cormio L, Di Fino G, Scavone C, Maroscia D, Mancini V, Ruocco N, Bellanti F, Selvaggio O, Sanguedolce F, Lucarelli G, Carrieri G.
Medicine (Baltimore). 2016 Apr;95(16):e3475. doi: 10.1097/MD.0000000000003475
PubMed PMID: 27100451; PubMed Central PMCID: PMC4845855

Absence of Bladder Outlet Obstruction Is an Independent Risk Factor for Prostate Cancer in Men Undergoing Prostate Biopsy
Cormio L, Lucarelli G, Selvaggio O, Di Fino G, Mancini V, Massenio P, Troiano F, Sanguedolce F, Bufo P, Carrieri G.
Medicine (Baltimore). 2016 Feb;95(7):e2551. doi: 10.1097/MD.0000000000002551
PubMed PMID: 26886598; PubMed Central PMCID: PMC4998598

Suprapubic-assisted Transurethral Excision of a Vaginal Mesh Eroded Into the Bladder
Cormio L, Liuzzi G, Massenio P, Ruocco N, Di Fino G, Mancini V, Selvaggio O, Carrieri G.
Urol Case Rep. 2015 Apr 7;3(3):84-5. doi: 10.1016/j.eucr.2015.03.004. eCollection 2015 May
PubMed PMID: 26793511; PubMed Central PMCID: PMC4714320

Post-void residual urinary volume is an independent predictor of biopsy results in men at risk for prostate cancer
Cormio L, Lucarelli G, Netti GS, Stallone G, Selvaggio O, Troiano F, Di Fino G, Sanguedolce F, Bufo P, Grandaliano G, Carrieri G.
Anticancer Res. 2015 Apr;35(4):2175-82
PubMed PMID: 25862875

Magnetic resonance imaging of penile paraffinoma: case report
Cormio L, Di Fino G, Scavone C, Selvaggio O, Massenio P, Sanguedolce F, Macarini L, Carrieri G.
BMC Med Imaging. 2014 Dec 8;14:39. doi: 10.1186/1471-2342-14-39
PubMed PMID: 25487566; PubMed Central PMCID: PMC4295304

Simultaneous radical nephroureterectomy and transurethral distal ureter balloon occlusion and detachment
Cormio L, Selvaggio O, Di Fino G, Massenio P, Sanguedolce F, Ciavotta G, Mancini V, Carrieri G.
World J Surg Oncol. 2014 Nov 15;12:345. doi: 10.1186/1477-7819-12-345
PubMed PMID: 25398501; PubMed Central PMCID: PMC4289158

Pentraxin 3: a novel biomarker for predicting progression from prostatic inflammation to prostate cancer
Stallone G, Cormio L, Netti GS, Infante B, Selvaggio O, Fino GD, Ranieri E, Bruno F, Prattichizzo C, Sanguedolce F, Tortorella S, Bufo P, Grandaliano G,
Carrieri G.
Cancer Res. 2014 Aug 15;74(16):4230-8. doi: 10.1158/0008-5472.CAN-14-0369
Epub 2014 Jun 20. PubMed PMID: 24950910

Osseous metaplasia within a urothelial bladder cancer nodal metastasis: a case
report
Cormio L, Sanguedolce F, Massenio P, Di Fino G, Selvaggio O, Bufo P, Carrieri G.
Anal Quant Cytopathol Histpathol. 2014 Apr;36(2):117-9
PubMed PMID: 24902364

Hem-o-lok clip: a neglected cause of severe bladder neck contracture and consequent urinary incontinence after robot-assisted laparoscopic radical prostatectomy
Cormio L, Massenio P, Lucarelli G, Di Fino G, Selvaggio O, Micali S, Carrieri G.
BMC Urol. 2014 Feb 20;14:21. doi: 10.1186/1471-2490-14-21
PubMed PMID: 24555468; PubMed Central PMCID: PMC3938024

An unusual delayed complication of paraffin self-injection for penile girth augmentation
De Siati M, Selvaggio O, Di Fino G, Liuzzi G, Massenio P, Sanguedolce F, Carrieri G, Cormio L.
BMC Urol. 2013 Dec 1;13:66. doi: 10.1186/1471-2490-13-66
PubMed PMID: 24289092; PubMed Central PMCID: PMC4219597

Prostate cancer detection rates in different biopsy schemes. Which cores for which patients?
Cormio L, Scattoni V, Lorusso F, Perrone A, Di Fino G, Selvaggio O, Sanguedolce F, Bufo P, Montorsi F, Carrieri G.
World J Urol. 2014 Apr;32(2):341-6. doi: 10.1007/s00345-012-0989-8
Epub 2012 Nov 25. PubMed PMID: 23184141

Transurethral distal ureter balloon occlusion and detachment: a simple means of managing the distal ureter during radical nephroureterectomy
Cormio L, Selvaggio O, Di Fino G, Massenio P, Annese P, de la Rosette J, Carrieri G.
J Endourol. 2013 Feb;27(2):139-42. doi: 10.1089/end.2012.0432
Epub 2012 Nov 7. PubMed PMID: 22905803

Combined perianal-intrarectal (PI) lidocaine-prilocaine (LP) cream and lidocaine-ketorolac gel provide better pain relief than combined PI LP cream and periprostatic nerve block during transrectal prostate biopsy
Cormio L, Pagliarulo V, Lorusso F, Selvaggio O, Perrone A, Sanguedolce F, Bufo P, Carrieri G.
BJU Int. 2012 Jun;109(12):1776-80. doi: 10.1111/j.1464-410X.2011.10622.x. Epub 2011 Oct 14
PubMed PMID: 21999406

Noninfiltrative anesthesia for transrectal prostate biopsy: a randomized prospective study comparing lidocaine-prilocaine cream and lidocaine-ketorolac gel
Cormio L, Lorusso F, Selvaggio O, Perrone A, Sanguedolce F, Pagliarulo V, Bufo P, Carrieri G.
Urol Oncol. 2013 Jan;31(1):68-73. doi: 10.1016/j.urolonc.2010.09.004
Epub 2011 Mar 10. PubMed PMID: 21396848

Oral L-citrulline supplementation improves erection hardness in men with mild erectile dysfunction
Cormio L, De Siati M, Lorusso F, Selvaggio O, Mirabella L, Sanguedolce F, Carrieri G.
Urology. 2011 Jan;77(1):119-22. doi: 10.1016/j.urology.2010.08.028
PubMed PMID: 21195829

Complete renal allograft calcification
Cormio L, Selvaggio O, Stallone G, Infante B, Di Fino G, Gesualdo L, Carrieri G.
Urology. 2009 Nov;74(5):1019. doi: 10.1016/j.urology.2009.04.035
Epub 2009 Jul 16. PubMed PMID: 19615718

Surgical treatment of Peyronie’s disease by plaque incision and grafting with buccal mucosa
Cormio L, Zucchi A, Lorusso F, Selvaggio O, Fioretti F, Porena M, Carrieri G.
Eur Urol. 2009 Jun;55(6):1469-75. doi: 10.1016/j.eururo.2008.11.041
Epub 2008 Dec 3. PubMed PMID: 19084325

Clinical Evidence Supporting the Role of Lonidamine for the Treatment of BPH
Ditonno P, Battaglia M, Selvaggio O, Garofalo L, Lorusso V, Selvaggi FP.
Rev Urol. 2005;7 Suppl 7:S27-33
PubMed PMID: 16986058; PubMed Central PMCID: PMC1477627

Double J stent with antireflux device in the prevention of short-term urological complications after cadaveric kidney transplantation: single-center prospective
randomized study
Battaglia M, Ditonno P, Selvaggio O, Palazzo S, Bettocchi C, Peschechera R, Di Paolo S, Stallone G, Schena A, Grandaliano G, D’Orazio E, Selvaggi FP.
Transplant Proc. 2005 Jul-Aug;37(6):2525-6
PubMed PMID: 16182733

Bilateral tumors of the testis in 21-alpha hydroxylase deficiency without adrenal hyperplasia
Battaglia M, Ditonno P, Palazzo S, Bettocchi C, Selvaggio O, Garofalo L, Selvaggi FP.
Urol Oncol. 2005 May-Jun;23(3):178-80
PubMed PMID: 15907717

The role of ultrasound and echo-color Doppler in the diagnosis and follow-up of tuberculosis of the transplanted kidney
Palazzo S, Martino P, Battaglia M, Ditonno P, Peschechera R, Selvaggio O, Selvaggi FP.
Arch Ital Urol Androl. 2005 Mar;77(1):73-5
PubMed PMID: 15906799

Medical and surgical complications after kidney transplantation from “suboptimal donors”: one centre’s experience
Battaglia M, Ditonno P, Selvaggio O, Peschechera R, Ricapito V, DeCeglie G, Schena A, Stallone G, Schena FP, Falagario M, Selvaggi FP.
Transplant Proc. 2004 Apr;36(3):493-4
PubMed PMID: 15110568

Kidney transplants from infected donors: our experience
Battaglia M, Ditonno P, Selvaggio O, Garofalo L, Palazzo S, Schena A, Stallone G, D’Orazio E, Selvaggi FP.
Transplant Proc. 2004 Apr;36(3):491-2
PubMed PMID: 15110567

Doppler color ultrasonography in the assessment of double kidney transplantation
Selvaggio O, Martino P, Palazzo S, Battaglia M, Ditonno P, Di Lorenzo V, Selvaggi FP.
Arch Ital Urol Androl. 2002 Dec;74(4):219-21. Italian
PubMed PMID: 12508735

Initial experience with a new transurethral microwave thermotherapy treatment protocol ’30-minute TUMT’
Pace G, Selvaggio O, Palumbo F, Selvaggi FP.
Eur Urol. 2001 Apr;39(4):405-11
PMID: 11306878

Efficacy and safety of the new high-energy 30-minute transurethral microwave thermotherapy: results of 1-year follow-up in a multicenter study
de La Rosette JJ, Laguna MP, Pace G, Kortmann BB, Selvaggio O, Debruyne FM,
Selvaggi FP.
Tech Urol. 2000 Dec;6(4):271-5
PubMed PMID: 11108564

Attualmente sono iscritto alle seguenti società:

• Società Italiana di Urologia
• European Association of Urology
• Società Italiana di Endurologia
• Società Italiana di Urologia Oncologica

Ho preso parte ai seguenti studi di sperimentazione clinica condotti secondo le Good Clinical Practice:

Protocollo TERRA
A multicenter, randomized, open clinical study to compare the efficacy and safety of a combination of Tacrolimus and Sirolimus versus Tacrolimus/Mycophenolate Mofetil based regimen in kidney transplantation
FG-506-02-39 TERRA

Protocollo STAR
Steroid treatment avoidance trough RAD: a 36-month, prospective, multicenter, parallel group open-label study to evaluate the impact on morbidity of two steroid treatment approaches (continuos vs tailored treatment) in patients receiving RAD in combination with Simulect® and Neoral® for the prophylaxis of acute rejection after kidney transplantation
CRAD001AIT01

Protocollo MO2ART
A 12-month, multicenter, randomized, open-label study to evaluate the benefit of C-2 hours monitoring of Neoral® and to compare the impact of two different maintenance ranges of C-2h levels on safety and efficacy outcomes in de novo kidney transplant recipients
NEORAL/COLO400A

Protocollo MYFORTIC
A twelve-month, randomized, multicenter, open-label study to investigate the clinical outcomes of two immunosuppressive regimens of Myfortic® with short-term steroid use or free of steroids compared with regimen of Myfortic® with standard steroids in de novo kidney recipients receiving Simulect® and Neoral®
CERL080A2404

Protocollo LONIDAMINA
A Phase II, open label dose comparison study of the safety, tolerability and efficacy of Lonidamine (LND) for the treatment of symptomatic benign prostatic hyperplasia
TH-CR-201

Protocollo FTY720
A one-year, multicenter, partially blinded, double dummy, randomized study to evaluate the efficacy and safety of FTY720 combined with reduced-dose or full-dose Neoral and corticosteroids versus mycophenolate mofetil (MMF, Cell-Cept) combined with full-dose Neoral and corticosteroids, in de novo adult renal transplant recipients.
CFTY720 0124

Protocollo A3711044
Studio pilota multi-centrico randomizzato a gruppi paralleli in doppio cieco controllato con placebo con intervallo della dose e con un controllo attivo per valutare l’efficacia e la sicurezza/tollerabilità di UK-369,003 a rilascio immediate e a rilascio modificato nel trattamento di uomini con sintomi delle basse vie urinarie (LUTS) con e senza disfunzione erettile

Protocollo ABITUDE
Studio osservazionale prospettico sui pazienti
con carcinoma prostatico metastatico resistente alla castrazione in progressione dopo terapia ormonale standard eleggibili al trattamento con Abiraterone Acetato